1. Home
  2. HRTX vs DBL Comparison

HRTX vs DBL Comparison

Compare HRTX & DBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HRTX
  • DBL
  • Stock Information
  • Founded
  • HRTX 1983
  • DBL 2011
  • Country
  • HRTX United States
  • DBL United States
  • Employees
  • HRTX N/A
  • DBL N/A
  • Industry
  • HRTX Biotechnology: Pharmaceutical Preparations
  • DBL
  • Sector
  • HRTX Health Care
  • DBL
  • Exchange
  • HRTX Nasdaq
  • DBL Nasdaq
  • Market Cap
  • HRTX 350.4M
  • DBL 280.4M
  • IPO Year
  • HRTX 1987
  • DBL N/A
  • Fundamental
  • Price
  • HRTX $2.11
  • DBL $15.50
  • Analyst Decision
  • HRTX Strong Buy
  • DBL
  • Analyst Count
  • HRTX 2
  • DBL 0
  • Target Price
  • HRTX $5.50
  • DBL N/A
  • AVG Volume (30 Days)
  • HRTX 1.8M
  • DBL 61.0K
  • Earning Date
  • HRTX 05-06-2025
  • DBL 01-01-0001
  • Dividend Yield
  • HRTX N/A
  • DBL 8.67%
  • EPS Growth
  • HRTX N/A
  • DBL N/A
  • EPS
  • HRTX N/A
  • DBL N/A
  • Revenue
  • HRTX $148,518,000.00
  • DBL N/A
  • Revenue This Year
  • HRTX $11.18
  • DBL N/A
  • Revenue Next Year
  • HRTX $13.15
  • DBL N/A
  • P/E Ratio
  • HRTX N/A
  • DBL N/A
  • Revenue Growth
  • HRTX 12.43
  • DBL N/A
  • 52 Week Low
  • HRTX $1.04
  • DBL $13.75
  • 52 Week High
  • HRTX $3.93
  • DBL $15.70
  • Technical
  • Relative Strength Index (RSI)
  • HRTX 47.04
  • DBL 50.86
  • Support Level
  • HRTX $2.00
  • DBL $15.13
  • Resistance Level
  • HRTX $2.61
  • DBL $15.65
  • Average True Range (ATR)
  • HRTX 0.18
  • DBL 0.18
  • MACD
  • HRTX -0.01
  • DBL 0.02
  • Stochastic Oscillator
  • HRTX 20.63
  • DBL 65.12

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

About DBL DoubleLine Opportunistic Credit Fund of Beneficial Interest

Doubleline Opportunistic Credit Fund operates as a closed-end management investment company. Its investment objective is to seek a high total investment return by providing a high level of current income and the potential for capital appreciation. The Fund invests in debt securities, residential and commercial mortgage-backed securities, asset-backed securities, U.S. Government securities, corporate debt, international sovereign debt, and short-term investments.

Share on Social Networks: